[HTML] springer.comFull View

[HTML][HTML] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - BMC medicine, 2017 - Springer
Abstract Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …
被引用次数：62 相关文章

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek… - BMC …, 2017 - search.proquest.com
Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even when
surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival …
[PDF] mnms-platform.com

[PDF][PDF] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - 2017 - mnms-platform.com
Abstract Background: Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …
[PDF] cyberleninka.org

[PDF][PDF] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - 2017 - cyberleninka.org
Abstract Background: Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - BMC Medicine, 2017 - infona.pl
Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even when
surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival …
[PDF] researchgate.net

[PDF][PDF] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - 2017 - researchgate.net
Abstract Background: Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …
[PDF] bilkent.edu.tr

[PDF][PDF] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - 2017 - repository.bilkent.edu.tr
Abstract Background: Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …
[PDF] core.ac.uk

[PDF][PDF] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - 2017 - core.ac.uk
Abstract Background: Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …
[HTML] nih.gov

[HTML][HTML] Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek… - BMC …, 2017 - ncbi.nlm.nih.gov
Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even when
surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival …

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.

S Battini, F Faitot, A Imperiale, AE Cicek… - BMC Medicine, 2017 - europepmc.org
Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even when
surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival …